Maia Biotechnology Stock Performance

MAIA Stock  USD 2.42  0.26  12.04%   
MAIA Biotechnology holds a performance score of 15 on a scale of zero to a hundred. The firm secures a Beta (Market Risk) of -0.55, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning MAIA Biotechnology are expected to decrease at a much lower rate. During the bear market, MAIA Biotechnology is likely to outperform the market. Use MAIA Biotechnology standard deviation, treynor ratio, downside variance, as well as the relationship between the total risk alpha and value at risk , to analyze future returns on MAIA Biotechnology.

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in MAIA Biotechnology are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady forward indicators, MAIA Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
12.04
Five Day Return
16.91
Year To Date Return
51.25
Ten Year Return
(45.74)
All Time Return
(45.74)
1
Acquisition by Smith Stan of 15000 shares of MAIA Biotechnology at 0.98 subject to Rule 16b-3
11/25/2025
2
How MAIA Biotechnology Inc. stock compares with top peers - Market Trend Summary Fast Gain Swing Alerts - Newser
12/04/2025
3
Acquisition by Smith Stan of 4580 shares of MAIA Biotechnology at 1.19 subject to Rule 16b-3
12/05/2025
4
Swing Trade Why hedge funds are buying MAIA Biotechnology Inc stock - July 2025 Movers Safe Entry Momentum Stock Tips - moha.gov.vn
12/19/2025
5
Acquisition by Louie Ngar Yee of 81699 shares of MAIA Biotechnology at 1.36 subject to Rule 16b-3
12/22/2025
6
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings
12/24/2025
7
Acquisition by Chaouki Steven M of 24633 shares of MAIA Biotechnology at 1.53 subject to Rule 16b-3
12/31/2025
8
Dr. Munique Maia Announces Harmony Surgery Center, a State-of-the-Art Surgical Center Opening in Tysons Corner in Early 2026
01/05/2026
9
MAIA Biotechnology Highlights Strategy in New Investor Presentation - TipRanks
01/13/2026
10
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc.
01/20/2026
11
Acquisition by Smith Stan of 24747 shares of MAIA Biotechnology at 1.8 subject to Rule 16b-3
01/22/2026
12
Microsoft Launches Maia 200 AI Chip for Faster Model Inference
01/26/2026
13
2 Stocks to Buy as Microsoft Announces Its New Maia 200 AI Chip
01/28/2026
14
MAIA Biotechnology announces significant insider buying - MSN
02/06/2026
15
MAIA Biotechnology, Inc. Sees Significant Growth in Short Interest - MarketBeat
02/17/2026
16
MAIA Biotechnologys Phase 3 MomentumDemonstrates PotentialBreakthroughAnticancerOpportunity in50 BillionImmunotherapy Market
02/24/2026
Begin Period Cash Flow7.2 M
Free Cash Flow-15.7 M

MAIA Biotechnology Relative Risk vs. Return Landscape

If you would invest  118.00  in MAIA Biotechnology on November 27, 2025 and sell it today you would earn a total of  124.00  from holding MAIA Biotechnology or generate 105.08% return on investment over 90 days. MAIA Biotechnology is currently generating 1.5439% in daily expected returns and assumes 8.0903% risk (volatility on return distribution) over the 90 days horizon. In different words, 72% of stocks are less volatile than MAIA, and 69% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days MAIA Biotechnology is expected to generate 10.58 times more return on investment than the market. However, the company is 10.58 times more volatile than its market benchmark. It trades about 0.19 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of risk.

MAIA Biotechnology Target Price Odds to finish over Current Price

The tendency of MAIA Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 2.42 90 days 2.42 
about 6.43
Based on a normal probability distribution, the odds of MAIA Biotechnology to move above the current price in 90 days from now is about 6.43 (This MAIA Biotechnology probability density function shows the probability of MAIA Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days MAIA Biotechnology has a beta of -0.55. This indicates as returns on the benchmark increase, returns on holding MAIA Biotechnology are expected to decrease at a much lower rate. During a bear market, however, MAIA Biotechnology is likely to outperform the market. Moreover MAIA Biotechnology has an alpha of 1.6868, implying that it can generate a 1.69 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   MAIA Biotechnology Price Density   
       Price  

Predictive Modules for MAIA Biotechnology

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MAIA Biotechnology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.153.0211.14
Details
Intrinsic
Valuation
LowRealHigh
0.244.7412.86
Details
Naive
Forecast
LowNextHigh
0.052.5610.68
Details
1 Analysts
Consensus
LowTargetHigh
11.0412.1313.47
Details

MAIA Biotechnology Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. MAIA Biotechnology is not an exception. The market had few large corrections towards the MAIA Biotechnology's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold MAIA Biotechnology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of MAIA Biotechnology within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
1.69
β
Beta against Dow Jones-0.55
σ
Overall volatility
0.50
Ir
Information ratio 0.19

MAIA Biotechnology Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of MAIA Biotechnology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for MAIA Biotechnology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
MAIA Biotechnology is way too risky over 90 days horizon
MAIA Biotechnology appears to be risky and price may revert if volatility continues
MAIA Biotechnology has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (23.25 M) with profit before overhead, payroll, taxes, and interest of 0.
MAIA Biotechnology currently holds about 8.15 M in cash with (15.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75.
MAIA Biotechnology has a poor financial position based on the latest SEC disclosures
Roughly 20.0% of the company outstanding shares are owned by corporate insiders
Latest headline from finance.yahoo.com: MAIA Biotechnologys Phase 3 MomentumDemonstrates PotentialBreakthroughAnticancerOpportunity in50 BillionImmunotherapy Market

MAIA Biotechnology Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of MAIA Stock often depends not only on the future outlook of the current and potential MAIA Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MAIA Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding22.2 M
Cash And Short Term Investments9.6 M
Shares Float32.1 M

MAIA Biotechnology Fundamentals Growth

MAIA Stock prices reflect investors' perceptions of the future prospects and financial health of MAIA Biotechnology, and MAIA Biotechnology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MAIA Stock performance.

About MAIA Biotechnology Performance

By analyzing MAIA Biotechnology's fundamental ratios, stakeholders can gain valuable insights into MAIA Biotechnology's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if MAIA Biotechnology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MAIA Biotechnology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Return On Tangible Assets(2.06)(2.16)
Return On Capital Employed(3.08)(3.24)
Return On Assets(2.06)(2.16)
Return On Equity(7.36)(6.99)

Things to note about MAIA Biotechnology performance evaluation

Checking the ongoing alerts about MAIA Biotechnology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MAIA Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
MAIA Biotechnology is way too risky over 90 days horizon
MAIA Biotechnology appears to be risky and price may revert if volatility continues
MAIA Biotechnology has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (23.25 M) with profit before overhead, payroll, taxes, and interest of 0.
MAIA Biotechnology currently holds about 8.15 M in cash with (15.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75.
MAIA Biotechnology has a poor financial position based on the latest SEC disclosures
Roughly 20.0% of the company outstanding shares are owned by corporate insiders
Latest headline from finance.yahoo.com: MAIA Biotechnologys Phase 3 MomentumDemonstrates PotentialBreakthroughAnticancerOpportunity in50 BillionImmunotherapy Market
Evaluating MAIA Biotechnology's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate MAIA Biotechnology's stock performance include:
  • Analyzing MAIA Biotechnology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MAIA Biotechnology's stock is overvalued or undervalued compared to its peers.
  • Examining MAIA Biotechnology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating MAIA Biotechnology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MAIA Biotechnology's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of MAIA Biotechnology's stock. These opinions can provide insight into MAIA Biotechnology's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating MAIA Biotechnology's stock performance is not an exact science, and many factors can impact MAIA Biotechnology's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for MAIA Stock analysis

When running MAIA Biotechnology's price analysis, check to measure MAIA Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MAIA Biotechnology is operating at the current time. Most of MAIA Biotechnology's value examination focuses on studying past and present price action to predict the probability of MAIA Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MAIA Biotechnology's price. Additionally, you may evaluate how the addition of MAIA Biotechnology to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data